| |
|
|
|
AcelRx Pharmaceuticals- Inc.  
|
|
2.95 0 (0%) |
07-20 16:00 |
|
Open: |
2.9 |
Pre close: |
2.95 |
Target:
|
4.35
|
|
High: |
3 |
Low: |
2.9 |
Resistance:
|
3.73
4.30
|
|
Volume: |
289,486 |
Market Cap: |
172M |
Support:
|
2.80
2.33
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.98
 |
MACD |
MACD(12,26):
|
-0.16 |
|
MA(20): |
3.40 |
Signal(12,26,9): |
-0.08 |
|
MA(100): |
2.80  |
Stochastic Oscillator |
%K(14,3):
|
11.93 |
|
MA(250): |
2.67 |
%D(3): |
13.52 |
|
Average Volume(K) |
3-Month: |
75307
|
52-Week |
High:
|
5.75 |
|
10-Days: |
107671 |
Low: |
1.55 |
|
RSI |
RSI(14):
|
36.95 |
Change(%): |
-19.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.000 |
Return on Equity (ttm) |
142.9 |
Shares Out. (M) |
51.32 |
|
EPS Est. Current Year |
-1.120 |
Return on Assets (ttm) |
-61.7 |
Shares Float (M) |
50.04 |
|
EPS Est. Next Year |
-0.940 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.50 |
|
EPS Est. Next Quarter |
-0.230 |
Qtrly Rev. Growth |
-89.0 |
% Held by Institutions |
18.50 |
|
Forward EPS |
-0.909 |
Gross Profit (p.s.) |
-0.028 |
Shares Short (K) |
3356 |
|
Book Value (p.s.) |
42.260 |
EBITDA (p.s.) |
-0.341 |
P/E |
-2.95 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.07 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-29.60 |
P/S |
1376309120.00 |
|
Operating Margin |
-667.01 |
Levered Free Cash Flow
(M) |
-26.29 |
P/CF |
-5.11 |
|
|
|
|
|
|
